Journal of Global Antimicrobial Resistance (Sep 2020)

Study of in vitro biological activity of thiazoles on Leishmania (Leishmania) infantum

  • Vinícius Vasconcelos Gomes de Oliveira,
  • Mary Angela Aranda de Souza,
  • Rafaela Ramos Mororó Cavalcanti,
  • Marcos Veríssimo de Oliveira Cardoso,
  • Ana Cristina Lima Leite,
  • Valdemiro Amaro da Silva Junior,
  • Regina Célia Bressan Queiroz de Figueiredo

Journal volume & issue
Vol. 22
pp. 414 – 421

Abstract

Read online

Objectives: In the prospection of possible agents against neglected diseases, thiazole compounds are presented as promising candidates and are known to have activity against trypanosomatid parasites. Thus, this work aimed to evaluate the effects of thiazole compounds on Leishmania infantum, the aetiological agent of visceral leishmaniasis. Methods: Thiazole compounds (five thiazoacetylpyridines [TAPs-01, -04, -05, -06, -09) and five thiazopyridines [TPs-01, -04, -05, -06, -09]) were tested regarding their leishmanicidal activity on both promastigote and amastigote forms of L. infantum. Cytotoxicity was tested using peritoneal macrophages of BALB/c mice. Ultrastructural analyses were performed to identify possible intracellular targets of the most effective compound on promastigote forms. To observe routes that can clarify the possible mechanism of action of the compounds on the intracellular amastigote forms, the nitrite dosage was performed. Results: All compounds inhibited the growth of promastigote and presented low cytotoxicity, being more selective to the parasite than to mammalian cells. All compounds tested were able to decrease macrophage infection. There was a significant decrease in the survival rate of the amastigote when compared with the untreated cells, with TAP-04 presenting the best index. TAP-04 induced ultrastructural changes that are related to cell death by apoptosis. None of the macrophage groups infected with L. infantum and subsequently treated showed increased nitrite release. Conclusions: The low toxicity to mammalian cells and the leishmanicidal activity observed demonstrate that the synthesis of drugs based in thiosemicarbazone nucleus, thiazole and pyridine derivatives are promising for the treatment of visceral leishmaniasis.

Keywords